EN

KO

GeneMatrix

Products
- Molecular Diagnostics
  
  Sexually Transmitted Infections
  
  NeoPlex™ STI-14 Detection
  
  NeoPlex™ STI-7 Detection
  
  NeoPlex™ STI-7 PLUS Detection
  
  Human Papillomavirus Infections
  
  NeoPlex™ HPV29 Detection
  
  NeoPlex™ HPV HR
  
  Respiratory Infections
  
  NeoPlex™ RV-Panel A Detection
  
  NeoPlex™ RV-Panel B Detection
  
  NeoPlex™ RB-8 Detection
  
  NeoPlex™ FluCOVID Detection
  
  NeoPlex™ COVID-19 FAST
  
  NeoPlex™ COVID-19 Detection
  
  Tuberculosis
  
  NeoPlex™ TB/NTM-5 Detection
  
  Gastrointestinal Infections
  
  NeoPlex™ GI-Virus 6 Detection
Experience NeoPlex™ for optimized user efficiency through multiplexing.

Maximize your diagnostic efficiency with our multiplex molecular diagnostic assays.
R&D
Single-tube Multiplex PCR

Explore GeneMatrix’s proprietary multiplex technology that enables simultaneous identification in a single tube.

Research for vaccine development

Explore our R&D capabilities to develop next-generation vaccines.
Support
- Resources
- Videos
- Inquiry
Product and academic inquiries

Connect with a product representative. We quickly respond to your inquiries.
About Us
GeneMatrix 20 years

Look at the GeneMatrix's milestones in pioneering innovation in the field of molecular diagnostics.
News
- News
- Conferences & Exhibitions
Latest news

Explore GeneMatrix's latest news and updates.

KO

News

Genematrix, acquires COVID-19 vaccine substitute materials and secured superior neutralizing antibodies for commercial vaccines

Oct 05, 2021

Medical today

https://www.mdtoday.co.kr/mdtoday/index.html?no=431347